Maryland's R&D credit: an annual pool, an application, and a small-company refund

Maryland's research and development tax credit is a rationed incentive: a fixed statewide pool, an annual application to the Maryland Department of Commerce, certification before claiming, and proration when — as is routine — requests exceed the pool. The program's historical design paired a basic component (a small percentage of Maryland qualified research expenses up to the base) with a growth component (a larger percentage, historically 10%, of expenses above the base); the legislature restructured the program in recent years, concentrating the benefit on growth and on small businesses, for whom the credit is refundable. As of mid-2026 the pool sits in the low tens of millions of dollars annually; verify the current structure and amounts with the Department of Commerce before relying on any figure here.

Structure: basic, growth, and the pool

The computation borrows federal Section 41 definitions applied to research performed in Maryland. The growth component pays a percentage — historically 10% — of Maryland QREs exceeding the Maryland base amount (an average of prior-year in-state spending); the basic component, where applicable, paid a lower percentage on spending up to the base. Because the legislature has revised which components exist and at what rates, model the mechanism and confirm the current-year parameters.

The pool is the binding constraint. Each component draws from a fixed annual appropriation, and when certified requests exceed it, every claimant is scaled down pro rata. In heavily subscribed years, a company computing a $100,000 credit may be certified for materially less.

The table summarizes the program's moving parts as of mid-2026.

The small-business refund

Maryland pays qualifying small businesses their certified credit in cash to the extent it exceeds liability. Eligibility has been keyed to a small-business definition based on net book value of assets rather than revenue or headcount — an unusual test that can qualify a well-funded startup with modest fixed assets while excluding an asset-heavy small manufacturer. For loss-stage companies in Maryland's biotech and cybersecurity corridors, this converts the credit from a deferred asset into funding, subject always to the pool haircut. How that compares to other states' cash routes is covered in refundable and transferable state credits.

Mechanics, fit, and the trap

The sequence is: incur Maryland QREs in year one; apply to Commerce by the deadline in year two; receive certification; claim the certified amount on the Maryland return filed with the Comptroller (the Comptroller of Maryland administers the return side). Documentation travels with the application — Maryland reviews before certifying, not after claiming.

The credit fits companies with growing Maryland research spending, and especially small companies eligible for the refund. It fits poorly for companies with flat in-state spending (the growth design pays little) and for anyone allergic to paperwork deadlines.

The trap is the one the structure advertises: the application deadline and the pool. There is no amended-return rescue for a missed November filing — the year is gone. And even a timely, well-documented application can be prorated, so the credit should never be booked at its computed amount until certification arrives. A quieter second trap: base-period data must be Maryland-sourced, and companies new to the state often overstate the credit by treating their whole federal QRE pool as Maryland spending. The sourcing discipline described in how state credits differ applies with force; neighboring Virginia runs a similar application-and-pool design worth comparing.